Thome M - Search Results

1

Expanded murine regulatory T cells: analysis of phenotype and function in contact hypersensitivity reactions.

Ring S, Thome M, Pretsch L, Enk AH, Mahnke K. Ring S, et al. Among authors: thome m. J Immunol Methods. 2007 Sep 30;326(1-2):10-21. doi: 10.1016/j.jim.2007.06.007. Epub 2007 Jul 16. J Immunol Methods. 2007. PMID: 17689553

2

Expression of the heat shock cognate protein HSP73 correlates with tumour thickness of primary melanomas and is enhanced in melanoma metastases.

Deichmann M, Polychronidis M, Benner A, Kleist C, Thome M, Kahle B, Helmke BM. Deichmann M, et al. Among authors: thome m. Int J Oncol. 2004 Aug;25(2):259-68. Int J Oncol. 2004. PMID: 15254721

3

The protein phosphatase 2A subunit Bgamma gene is identified to be differentially expressed in malignant melanomas by subtractive suppression hybridization.

Deichmann M, Polychronidis M, Wacker J, Thome M, Näher H. Deichmann M, et al. Among authors: thome m. Melanoma Res. 2001 Dec;11(6):577-85. doi: 10.1097/00008390-200112000-00004. Melanoma Res. 2001. PMID: 11725204

4

Analysis of losses of heterozygosity of the candidate tumour suppressor gene DMBT1 in melanoma resection specimens.

Deichmann M, Mollenhauer J, Helmke B, Thome M, Hartschuh W, Poustka A, Näher H. Deichmann M, et al. Among authors: thome m. Oncology. 2002;63(2):166-72. doi: 10.1159/000063802. Oncology. 2002. PMID: 12239452

5

PTEN/MMAC1 expression in melanoma resection specimens.

Deichmann M, Thome M, Benner A, Egner U, Hartschuh W, Näher H. Deichmann M, et al. Among authors: thome m. Br J Cancer. 2002 Dec 2;87(12):1431-6. doi: 10.1038/sj.bjc.6600653. Br J Cancer. 2002. PMID: 12454773 Free PMC article.

6

B-raf exon 15 mutations are common in primary melanoma resection specimens but not associated with clinical outcome.

Deichmann M, Thome M, Benner A, Näher H. Deichmann M, et al. Among authors: thome m. Oncology. 2004;66(5):411-9. doi: 10.1159/000079490. Oncology. 2004. PMID: 15331929

7

Somatic mitochondrial mutations in melanoma resection specimens.

Deichmann M, Kahle B, Benner A, Thome M, Helmke B, Näher H. Deichmann M, et al. Among authors: thome m. Int J Oncol. 2004 Jan;24(1):137-41. Int J Oncol. 2004. PMID: 14654950

8

The oncogenic B-raf V599E mutation occurs more frequently in melanomas at sun-protected body sites.

Deichmann M, Krahl D, Thome M, Wüst K, Hassanzadeh J, Helmke B. Deichmann M, et al. Among authors: thome m. Int J Oncol. 2006 Jul;29(1):139-45. Int J Oncol. 2006. PMID: 16773193

9

Preponderance of the oncogenic V599E and V599K mutations in B-raf kinase domain is enhanced in melanoma cutaneous/subcutaneous metastases.

Deichmann M, Thome M, Benner A, Kirschner M, Hassanzadeh J, Kurzen H. Deichmann M, et al. Among authors: thome m. BMC Cancer. 2005 Jun 3;5:58. doi: 10.1186/1471-2407-5-58. BMC Cancer. 2005. PMID: 15935100 Free PMC article.

10

The chemoresistance gene ABCG2 (MXR/BCRP1/ABCP1) is not expressed in melanomas but in single neuroendocrine carcinomas of the skin.

Deichmann M, Thome M, Egner U, Hartschuh W, Kurzen H. Deichmann M, et al. Among authors: thome m. J Cutan Pathol. 2005 Aug;32(7):467-73. doi: 10.1111/j.0303-6987.2005.00359.x. J Cutan Pathol. 2005. PMID: 16008690

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

188 results

Search Page

Filters